The crystal structure of α-thrombin-hirunorm IV complex reveals a novel specificity site recognition mode

Protein Science

Volumn 8, Issue 1, 1999, Pages 91-95

  Lombardi, Angela ^a   De Simone, Giuseppina ^a   Nastri, Flavia ^a   Galdiero, Stefania ^a   Della Morte, Rossella ^a   Staiano, Norma ^a   Pedone, Carlo ^a   Bolognesi, Martino ^b,c   Pavone, Vincenzo ^a,d  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b UNIVERSITY OF PAVIA   (Italy)

^c UNIVERSITY OF GENOA   (Italy)

^d Ctro Interuniversitario Ric su P   (Italy)

Author keywords

Bifunctional synthetic thrombin inhibitors; Crystal structure; Hirunorms; Retro binding peptides

Indexed keywords

ARGININE; FIBRINOGEN; GLYCINE; HIRUDIN DERIVATIVE; HIRUNORM IV; SERINE; THROMBIN; TRIPEPTIDE; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ARTICLE; CARBOXY TERMINAL SEQUENCE; COMPLEX FORMATION; CRYSTAL STRUCTURE; ENZYME ACTIVE SITE; HUMAN; MOLECULAR RECOGNITION; PRIORITY JOURNAL;

EID: 0032946325     PISSN: 09618368     EISSN: None     Source Type: Journal    
DOI: 10.1110/ps.8.1.91     Document Type: Article

References (32)

1. Abola EE, Sussman JL, Prilusky J, Manning NO. 1997. Protein data bank archives of three-dimensional macromolecular structures. Methods Enzymol 277:556-571.
2. Ascenzi P, Amiconi G, Bode W, Bolognesi M, Coletta M, Menegatti E. 1995. Proteinase inhibitors from the European medicinal leech Hirudo medicinalis: Structural functional and biomedical aspects. Molec Aspects Med 16:215-313.
3. Bode W, Mayr I, Baumann U, Huber R, Stone SR, Hofsteenge J. 1989. The refined 1.9 Å crystal structure of human α-thrombin: Interaction with D-Phe-Pro-Arg-chloromethylketone and significance of the Tyr-Pro-Pro-Trp insertion segment. EMBO J 8:3467-3475.
4. Bode W, Turk D, Karshikov A. 1992. The refined 1.9 Å X-ray crystal structure of D-Phe-Pro-Arg chloromethylketone-inhibited human α-thrombin: Structure analysis overall structure electrostatic properties detailed active-site geometry and structure-function relationships. Protein Sci 1:426-471.
5. Brandstetter H, Turk D, Hoeffken HW, Grosse D, Stürzebecher J, Martin PD, Ewards BFP, Bode W. 1992. Refined 2.3 Å X-ray crystal structure of bovine thrombin complexes formed with the benzamidine and arginine-based thrombin inhibitors NAPAP 4-TAPAP and MQPA. J Mol Biol 226:1085-1099.
6. 1994. The CCP4 suite: Programs for protein crystallography. Acta Crystallogr D50:760-767.
7. De Simone G, Lombardi A, Galdiero S, Nastri F, Della Morte R, Staiano N, Pedone C, Bolognesi M, Pavone V. 1998. Hirunorms are true hirudin mimetics: The crystal structure of human α-thrombin-hirunorm V complex. Protein Sci 7:243-253.
8. Di Cera E, Dand QD, Ayala YM. 1997. Molecular mechanism of thrombin function. Cell Mol Life Sci 53:701-730.
9. Engh RA, Huber R. 1991. Accurate bond and angle parameters for X-ray protein structure refinement. Acta Crystallogr A47:392-400.
10. Fenton JW II. 1988. Thrombin specificity. Ann NY Acad Sci 370:468-495.
11. Fenton JW II, Bing DH. 1986. Thrombin active-site regions. Semin Thromb Haemostasis 12:200-208.
12. Féthière J, Tsuda Y, Coulombe R, Konishi Y, Cygler M. 1996. Crystal structure of two new bifunctional nonsubstrate type thrombin inhibitors complexed with human α-thrombin. Protein Sci 5:1174-1183.
13. Grütter MG, Priestle JP, Raquel J, Grossenbacher H, Bode W, Hofsteenge J, Stone SR. 1990. Crystal structure of the thrombin-hirudin complex: A novel mode of serine proteinase inhibition. EMBO J 9:2361-2365.
14. Jones TA, Zou J-Y, Cowan S, Kieldgaard M. 1991. Improved methods for building protein models in electron density maps and location of errors in these models. Acta Crystallogr A47:110-119.
15. Leslie AGW. 1992. Joint CCP4 and ESF-EACBM newsletter on protein crystallography No 26. Warrington, United Kingdom: Daresbury Laboratory.
16. Lombardi A, Nastri F, Della Morte R, Rossi A, De Rosa A, Staiano N, Pedone C, Pavone V. 1996. Rational design of true hirudin mimetics: Synthesis and characterization of multisite directed α-thrombin inhibitors. J Med Chem 39:2008-2017.
17. Markwardt F. 1994. The development of hirudin as an antithrombotic drug. Thrombosis Res 74:1-23.
18. Nienaber VL, Amparo EC. 1996. A noncleavable retrobinding peptide that spans the substrate binding cleft of serine proteases. Atomic structure of nazumamide A: Human thrombin. J Am Chem Soc 118:6807-6810.
19. Pavone V, De Simone G, Nastri F, Galdiero S, Staiano N, Lombardi A, Pedone C. 1998. Multiple binding mode of reversible synthetic thrombin inhibitors. A comparative structural analysis. Biol Chem 379:987-1006.
20. Rydel TJ, Ravichandran KG, Tulinsky A, Bode W, Huber R, Roitsch C, Fenton JW. 1990. The structure of a complex of recombinant hirudin and human α-thrombin. Science 249:277-280.
21. Rydel TJ, Tulinsky A, Bode W, Huber R. 1991. Refined structure of the hirudin-thrombin complex. J Mol Biol 221:583-601.
22. Schechter I, Berger A. 1967. On the size of the active-site in proteinases I Papain. Biochem Biophys Res Commun 27:157-162.
23. Skrzypczak-Jankun E, Carperos VE, Ravichandran KG, Tulinsky A, Westbrook M, Maraganore JM. 1991. Structure of hirugen and hirulog 1 complexes of α-thrombin. J Mol Biol 221:1379-1393.
24. Steiner V, Knecht R, Borsen KO, Gassmann E, Stone SR, Raschdorf F, Schlaeppi J-M, Maschler R. 1992. Primary structure and function of novel O-glycosylated hirudins from the leech Hirudinaria manillensis. Biochemistry 31:2294-2298.
25. Strube K-H, Kröger B, Bialojan S, Otte M, Dodt J. 1993. Isolation, sequence analysis, and cloning of Haemadin. J Biol Chem 268:8590-8595.
26. Stubbs MT, Bode W. 1993. A player of many parts: The spotlight falls on thrombin's structure. Thromb Res 69:1-58.
27. Stubbs MT, Bode W. 1995. Structure and specificity in coagulation and its inhibition. Trends Cardiovasc Med 5:157-166.
28. Tabernero L, Chang CY, Ohringer SL, Lau WF, Iwanowicz EJ, Han W, Wang TC, Seiler SM, Roberts DGM, Sack JS. 1995. Structure of a retrobinding peptide inhibitor complexed with human α-thrombin. J Mol Biol 246: 14-20.
29. Tapparelli C, Metternich R, Ehrhardt C, Cook NS. 1993. Synthetic low molecular weight thrombin inhibitors: Molecular design and pharmacological profile. Trends Pharmacol Sci 14:366-376.
30. Tronrud D, TenEyck LF, Matthews BW. 1987. An efficient general purpose least squares refinement program for macromolecular structures. Acta Crystallogr A34:489-501.
31. van de Locht A, Stubbs MT, Bode W, Friedrich T, Bollschweiler C, Höffken W, Huber R. 1996. The ornithodorin-thrombin crystal structure - A key to the TAP enigma? EMBO J 15:6011-6017.
32. Vitali J, Martin PD, Malkowski MD, Robertson WD, Lazar JB, Winant RC, Johnson PJ, Edwards BFP. 1992. The structure of a complex of bovine α-thrombin and recombinant hirudin at 2.8 Å resolution. J Biol Chem 267:17670-17678.